Reduction of isoforms of 15-lipoxygenase (15-LOX)-1 and 15-LOX-2 in human breast cancer.

[1]  I. Barshack,et al.  Inhibition of carcinogenesis in transgenic mouse models over-expressing 15-lipoxygenase in the vascular wall under the control of murine preproendothelin-1 promoter. , 2005, Cancer letters.

[2]  G. Watkins,et al.  Targeting Matrilysin and Its Impact on Tumor Growth In vivo: The Potential Implications in Breast Cancer Therapy , 2005, Clinical Cancer Research.

[3]  G. Watkins,et al.  Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes. , 2005, European journal of cancer.

[4]  Dao-Hai Zhang,et al.  Proteomics of breast cancer: Enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors , 2005, Proteomics.

[5]  P. Bongrand,et al.  Regulation of cell adhesion. , 2005, Clinical hemorheology and microcirculation.

[6]  G. Watkins,et al.  The localisation and reduction of nuclear staining of PPARgamma and PGC-1 in human breast cancer. , 2004, Oncology reports.

[7]  C. Liu,et al.  Transcriptional regulation of 15-lipoxygenase expression by promoter methylation. , 2004, Experimental cell research.

[8]  P. Massion,et al.  15-Lipoxygenase-2 expression in benign and neoplastic lung: an immunohistochemical study and correlation with tumor grade and proliferation. , 2004, Human pathology.

[9]  U. Kelavkar,et al.  15-lipoxygenase-1 expression upregulates and activates insulin-like growth factor-1 receptor in prostate cancer cells. , 2004, Neoplasia.

[10]  T. Eling,et al.  15-Lipoxygenase-1 has anti-tumorigenic effects in colorectal cancer. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.

[11]  G. Watkins,et al.  Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  G. Chen,et al.  15‐hydroxy‐eicosatetraenoic acid arrests growth of colorectal cancer cells via a peroxisome proliferator‐activated receptor gamma‐dependent pathway , 2003, International journal of cancer.

[13]  R. Mansel,et al.  Levels of expression of lipoxygenases and cyclooxygenase-2 in human breast cancer. , 2003, Prostaglandins, leukotrienes, and essential fatty acids.

[14]  R. Mansel,et al.  Expression of peroxisome‐proliferator activated receptor‐gamma (PPARγ) and the PPARγ co‐activator, PGC‐1, in human breast cancer correlates with clinical outcomes , 2003 .

[15]  S. Lippman,et al.  Reduced 15S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398. , 2003, Neoplasia.

[16]  B. Wong,et al.  15-Lipoxygenase-1 mediates cyclooxygenase-2 inhibitor-induced apoptosis in gastric cancer. , 2003, Carcinogenesis.

[17]  T. Eling,et al.  Opposing Effects of 15-Lipoxygenase-1 and -2 Metabolites on MAPK Signaling in Prostate , 2002, The Journal of Biological Chemistry.

[18]  R. Mansel,et al.  Molecular detection of micro-metastasis in breast cancer. , 2002, Critical reviews in oncology/hematology.

[19]  Dhyan Chandra,et al.  Evidence That Arachidonate 15-Lipoxygenase 2 Is a Negative Cell Cycle Regulator in Normal Prostate Epithelial Cells* 210 , 2002, The Journal of Biological Chemistry.

[20]  U. Kelavkar,et al.  Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis. , 2001, Carcinogenesis.

[21]  H. Kamitani,et al.  Evaluation of the activity and localization of 15-lipoxygenase-1 after introduction into human colorectal carcinoma Caco-2 cells. , 2001, Prostaglandins, leukotrienes, and essential fatty acids.

[22]  Rajnish A. Gupta,et al.  15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells. , 2001, Cancer research.

[23]  S. Lippman,et al.  15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. , 2000, Journal of the National Cancer Institute.

[24]  R. Mansel,et al.  Peroxisome proliferator activated receptor-γ (PPAR-γ) mediates the action of gamma linolenic acid in breast cancer cells , 2000 .

[25]  U. Kelavkar,et al.  Effects of mutant p53 expression on human 15-lipoxygenase-promoter activity and murine 12/15-lipoxygenase gene expression: evidence that 15-lipoxygenase is a mutator gene. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[26]  D F Horrobin,et al.  Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications. , 1998, Critical reviews in oncology/hematology.

[27]  W. Jiang.  Regulation of cell adhesion, a central mechanism in the anticancer action of essential fatty acids (review). , 1998, International journal of molecular medicine.

[28]  F. García-Carmona,et al.  Hydroperoxidative oxidation of diethylstilbestrol by lipoxygenase. , 1997, Archives of biochemistry and biophysics.

[29]  T. McDonnell,et al.  Regulation of lipid signaling pathways for cell survival and apoptosis by bcl-2 in prostate carcinoma cells. , 1997, Experimental cell research.

[30]  A. Brash,et al.  Discovery of a second 15S-lipoxygenase in humans. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[31]  I. Nazarenko,et al.  A closed tube format for amplification and detection of DNA based on energy transfer. , 1997, Nucleic acids research.

[32]  W. Glasgow,et al.  Characterization of a 15-lipoxygenase in human breast carcinoma BT-20 cells: stimulation of 13-HODE formation by TGF alpha/EGF. , 1997, Biochemical and biophysical research communications.

[33]  M. H. Lee,et al.  Aspirin-Triggered Lipoxins (15-epi-LX) Are Generated by the Human Lung Adenocarcinoma Cell Line (A549)–Neutrophil Interactions and Are Potent Inhibitors of Cell Proliferation , 1996, Molecular medicine.

[34]  R. Mansel,et al.  Inhibition of membrane ruffling and ezrin translocation by gamma linolenic acid. , 1996, International journal of oncology.

[35]  K. Kashfi,et al.  The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells. , 1996, Biochimica et biophysica acta.

[36]  J. Bronstein,et al.  Decreased levels of 13-hydroxyoctadecadienoic acid (13-HODE) dehydrogenase in neoplastic tissue of human colon biopsies. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[37]  J. Vanderhoek,et al.  Characterization of specific subcellular 15-hydroxyeicosatetraenoic acid (15-HETE) binding sites on rat basophilic leukemia cells. , 1995, Biochimica et biophysica acta.

[38]  V. D’Agati,et al.  Immunohistochemical demonstration of 15-lipoxygenase in transplant coronary artery disease. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[39]  B. Fisch,et al.  Effects of oestrogen on progesterone synthesis and arachidonic acid metabolism in human luteal cells , 1994, Clinical endocrinology.

[40]  J. Bronstein,et al.  Increases in 13-hydroxyoctadecadienoic acid dehydrogenase activity during differentiation of cultured cells. , 1993, Carcinogenesis.

[41]  K. Matsumoto,et al.  Effects of estrogen on cell proliferation and leukotriene formation in transformed mouse Leydig cells cultured under serum-free conditions. , 1990, Cancer research.

[42]  S. Yamamoto,et al.  Cloning and sequence analysis of the cDNA for arachidonate 12-lipoxygenase of porcine leukocytes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[43]  R. Dixon,et al.  Molecular cloning and primary structure of human 15-lipoxygenase. , 1988, Biochemical and biophysical research communications.

[44]  S. Murota,et al.  Stimulation of 12-lipoxygenase activity in rat platelets by 17β-estradiol , 1982 .

[45]  E. Aaes-Jørgensen,et al.  Essential fatty acids. , 1961, Physiological reviews.